Adjuvant chemotherapy of non-small cell lung cancer.

Tanaffos · 2012 · PMC4153177 · PMID 25191395

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Meta-analysis of early trials A meta-analysis of early adjuvant chemotherapy trials suggested an increase in the 5-year survival rate of absolute 5% by cisplatin-based chemotherapy but this difference did not reach statistical significance ( 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.